Filter
2252
Filtered Results: 2252
Text search:
drug
interactions
Featured
Recommendations
221
New Publications
540
Language
Document type
No document type
1434
Studies & Reports
290
Guidelines
285
Manuals
103
Strategic & Response Plan
55
Training Material
41
Fact sheets
32
Situation Updates
8
Resource Platforms
2
Infographics
2
Countries / Regions
India
129
Global
75
Kenya
72
South Africa
62
Ethiopia
49
Western and Central Europe
48
Nigeria
45
Nepal
43
Uganda
41
Tanzania
40
Sierra Leone
35
Malawi
35
Latin America and the Carribbean
33
Liberia
31
Zambia
29
Ghana
27
Bangladesh
27
Africa
25
Ukraine
23
Myanmar / Burma
22
Rwanda
21
Namibia
21
Eastern Europe
19
Cambodia
16
Russia
16
Lesotho
15
Philippines
15
Botswana
15
South–East Asia Region
14
Zimbabwe
12
Asia
11
Congo, Democratic Republic of
11
Eswatini/ Swaziland
9
Syria
8
Mozambique
8
USA
8
Eastern Europe and Central Asia
7
Indonesia
7
Germany
6
West and Central Africa
6
Middle East and North Africa
6
Tajikistan
5
Brazil
5
South Sudan
5
Thailand
4
Afghanistan
4
Haiti
4
North America
4
East and Southern Africa
4
Georgia
4
Pakistan
4
Chile
3
Cameroon
3
Albania
3
Laos
3
Burkina Faso
3
Guinea
3
Western Pacific Region
3
United Kingdom
3
Vietnam
3
North Macedonia
2
Colombia
2
Kazakhstan
2
Kyrgyzstan
2
Peru
2
Armenia
2
Argentina
2
Sri Lanka
2
Sudan
2
Yemen
2
Iraq
2
Switzerland
1
Timor Leste/ East Timor
1
Mexico
1
El Salvador
1
Turkey
1
Benin
1
Gambia
1
China
1
Iran
1
Canada
1
Senegal
1
Estonia
1
Austria
1
Qatar
1
Venezuela
1
Ireland
1
Turkmenistan
1
Jamaica
1
Belgium
1
Maldives
1
Spain
1
Belarus
1
Southern Africa
1
Bolivia
1
Papua New Guinea
1
Palestine
1
Libya
1
Solomon Islands
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
770
Clinical Guidelines
237
Public Health
136
Women & Child Health
70
Key Resources
53
Capacity Building
47
Pharmacy & Technologies
11
Toolboxes
Mental Health
327
HIV
260
TB
230
COVID-19
97
AMR
88
NTDs
78
Pharmacy
62
NCDs
50
Caregiver
44
Disability
39
Planetary Health
37
Ebola & Marburg
32
Global Health Education
30
Rapid Response
28
Refugee
20
Conflict
13
Polio
10
Specific Hazards
8
Social Ethics
8
Health Financing Toolbox
8
Malaria
7
Cholera
6
Natural Hazards
5
Zika
2
Interim rapid response guidance, 10 June 2022.
It includes considerations for certain populations such as patients with mild disease with considerations for community care, patients with moderate to severe disease, sexually active persons, pregnant or breastfeeding women, children and young persons...
The 2023 update of the Global Strategy for Asthma Management and Prevention incorporates new scientific information about asthma based on a review of recent scientific literature by an international panel of experts on the GINA Science Committee. This comprehensive and practical resource about one o...
What it is and what you can do
Rev. Oct16 770-10-0003
This curricula guide builds on several existing products of WHO and partners, aimed at supporting countries in their effort to address the first objective of the GAP-AMR (to improve awareness and understanding of AMR). It is targeted specifically at health educators and policy planners, and applies ...
The WHO Guidance on community mental health services: Promoting person-centred and rights-based approaches document is part of the WHO Guidance and technical packages on community mental health services set of publications. It provides a detailed description of person-centred and human rights-based ...
This publication offers practical advice on implementing HIV and STI programmes for transgender people, with a focus on transgender women, aligned with the 2011 Recommendations and the 2014 Key Populations Consolidated Guidelines. It contains examples of good practice from around the world that may ...
Note d’information scientifique, 17 juin 2021
Integrated Management of Adolescent and Adult Illness
Integrated Management of Childhood Illness
Interim Guidelines for health workers at health centre or district hospital outpatient clinic
The evidence base for differentiated care for stable patients has grown in recent years. There has been less attention, however, to developing differentiated models of care for patients with advanced or unstable HIV disease. Current clinical guidelines and policies regarding optimal packages of care...
WHO Model Formulary for Children
recommended
WHO Model Formulary for children based on the Second Model List of Essential Medicines for Children 2009.
In 2007, the World Health Assembly passed a Resolution titled ‘Better Medicines for Children’. This resolution recognized the need for research and development into medicines for children,...
As of 31 October 2020 This is the tenth edition of this summary of rapid systematic reviews, which includes the results of a rapid systematic review of currently available literature. More than 200 therapeutic options or their combinations are being investigated in more than 1,700 clinical trials. I...
Women and Health Initiative Working Paper No. 1. Women and Health Initiative
Improving maternal health in the context of the sub-Saharan African HIV epidemic requires greater understanding of the relationships between HIV disease and maternal morbidity and mortality, integrated and effective resp...
Improving maternal health in the context of the sub-Saharan African HIV epidemic requires greater understanding of the relationships between HIV disease and maternal morbidity and mortality, integrated and effective resp...
Journal of the International AIDS Society 2016, 19:20926
There is a growing interest in the potential contribution the private sector can make towards increasing access to antiretroviral therapy (ART) in low‐ and middle‐income settings. This article describes a public–private partnership ...
There is a growing interest in the potential contribution the private sector can make towards increasing access to antiretroviral therapy (ART) in low‐ and middle‐income settings. This article describes a public–private partnership ...
Psoriasis, which can involve the skin, nails and joints, is a chronic, painful, disfiguring and disabling noncommunicable disease (NCD) for which there is no cure. It negatively impacts on quality of life. Some of those who suffer from the disease develop chronic, inflammatory arthritis (psoriatic a...
